JP Morgan Chase’s Daxor DXR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$47 Sell
4
-2
-33% -$21 ﹤0.01% 7902
2026
Q2
$61 Buy
6
+5
+500% +$51 ﹤0.01% 7574
2026
Q1
$10 Sell
1
-4
-80% -$49 ﹤0.01% 7431
2025
Q4
$74 Buy
5
+1
+25% +$13 ﹤0.01% 7234
2025
Q3
$54 Hold
4
– – ﹤0.01% 7215
2025
Q2
$39 Hold
4
– – ﹤0.01% 6912
2025
Q1
$33 Sell
4
-1
-20% -$8 ﹤0.01% 7045
2024
Q4
$38 Hold
5
– – ﹤0.01% 7177
2024
Q3
$43 Hold
5
– – ﹤0.01% 7142
2024
Q2
$48 Hold
5
– – ﹤0.01% 7035
2024
Q1
$42 Buy
5
+1
+25% +$9 ﹤0.01% 7071
2023
Q4
$38 Buy
4
+2
+100% +$17 ﹤0.01% 7242
2023
Q3
$18 Buy
+2
New +$19 ﹤0.01% 7191

Other funds holding DXR

JP Morgan Chase's DXR Position: Q3 2026 in Review

JP Morgan Chase reduced its Daxor (DXR) stake by 33% in Q3 2026, selling an estimated $21 and leaving 4 shares worth $47. The position accounts for ﹤0.01% of the portfolio, ranked #7902.

JP Morgan Chase first reported a position in DXR in Q3 2023 and has held it in 13 quarters since. The position peaked at $74 in Q4 2025. 15 funds tracked by Wall St. Rank hold DXR as of Q3 2026.

  • JP Morgan Chase held 4 shares of Daxor worth $47 as of Q3 2026.
  • JP Morgan Chase sold 2 Daxor shares in Q3 2026, an estimated $21.
  • Daxor made up ﹤0.01% of JP Morgan Chase's portfolio in Q3 2026, its #7902 holding.
  • JP Morgan Chase first reported a position in Daxor in Q3 2023 and has held it in 13 quarters since.
  • JP Morgan Chase's Daxor position peaked at $74 in Q4 2025.
  • 15 funds tracked by Wall St. Rank held Daxor as of Q3 2026.

Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.